|

a SIngle Center Study of Post-operative STEReotactic RAdiotherapY for Endometrial Cancer

RECRUITINGN/ASponsored by ARNAS Civico Di Cristina Benfratelli Hospital
Actively Recruiting
PhaseN/A
SponsorARNAS Civico Di Cristina Benfratelli Hospital
Started2025-05-02
Est. completion2026-05
Eligibility
Age18 Years – 80 Years
SexFEMALE
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT06360653

Summary

The primary endpoint of the present prospective study is to assess the outcomes in terms of acute toxicity of post-operative stereotactic radiotherapy for endometrial cancer

Eligibility

Age: 18 Years – 80 YearsSex: FEMALEHealthy volunteers accepted
* Age 18-80 years
* ECOG PS ≤ 2 or KPS ≥ 70%
* Patients diagnosed with endometrial cancer (endometrioid, serous cell, clear cell, carcinosarcoma) FIGO stage IB-IIIC1 candidate to post-operative external beam radiotherapy, based on molecular and histological findings
* Indications for chemotherapy and/or brachytherapy are not exclusion criteria for the purpose of the study
* Written Informed Consent

Exclusion Criteria:

* Prior pelvic radiotherapy
* Para-aortic lymph nodes involvement
* ECOG PS ≥ 3
* Any diagnosis of inflammatory bowel disease (both active or quiescent)

Conditions2

CancerEndometrial Cancer

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.